Antares Pharma

Antares Pharma EBIT

Delisted

The EBIT of Antares Pharma (ATRS) as of Nov 18, 2026 is 65.93 M USD. In the previous year, EBIT was 13.71 M USD — a change of 380.98% (higher).

EBIT

65.93 MUSD

YoY

380.98%

Last updated:

In 2021, Antares Pharma's EBIT was 65.93 M USD, a 380.98% increase from the 13.71 M USD EBIT recorded in the previous year.

The Antares Pharma EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2019
992,000.00 USD
Jan 1, 2020
13.71 M USD
Jan 1, 2021
65.93 M USD
Jan 1, 2022 (e)
20.95 M USD
Jan 1, 2023 (e)
52.06 M USD
Jan 1, 2024 (e)
82.17 M USD
Jan 1, 2025 (e)
163.66 M USD
Jan 1, 2026 (e)
332.52 M USD
The Antares Pharma EBIT history
YEAREBITYoY
est332.52 MUSD+103.17%
est163.66 MUSD+99.19%
est82.17 MUSD+57.83%
est52.06 MUSD+148.51%
est20.95 MUSD-68.23%
65.93 MUSD+380.98%
13.71 MUSD+1,281.85%
992,000.00USD-125.83%
-3.84 MUSD-74.93%
-15.32 MUSD-36.47%
-24.12 MUSD+17.86%
-20.46 MUSD-41.73%
-35.11 MUSD+68.41%
-20.85 MUSD+82.08%
-11.45 MUSD+158.10%
-4.44 MUSD-26.38%
-6.03 MUSD-37.83%
-9.69 MUSD-20.53%
-12.20 MUSD+41.09%
-8.65 MUSD+4.46%
-8.28 MUSD-3.64%
-8.59 MUSD+2.56%
-8.37 MUSD-3.00%
-8.63 MUSD-15.86%
-10.26 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Antares Pharma Revenue

Antares Pharma Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
123.86 M USD
992,000.00 USD
-2.03 M USD
Jan 1, 2020
149.60 M USD
13.71 M USD
56.20 M USD
Jan 1, 2021
183.98 M USD
65.93 M USD
46.29 M USD
Jan 1, 2022 (e)
210.84 M USD
20.95 M USD
13.67 M USD
Jan 1, 2023 (e)
261.04 M USD
52.06 M USD
37.59 M USD
Jan 1, 2024 (e)
303.46 M USD
82.17 M USD
58.90 M USD
Jan 1, 2025 (e)
353.84 M USD
163.66 M USD
123.50 M USD
Jan 1, 2026 (e)
420.84 M USD
332.52 M USD
264.12 M USD

Antares Pharma Margins

Antares Pharma stock margins

The Antares Pharma margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Antares Pharma. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Antares Pharma.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
59.25 %
0.80 %
-1.64 %
Jan 1, 2020
57.82 %
9.16 %
37.57 %
Jan 1, 2021
62.89 %
35.84 %
25.16 %
Jan 1, 2022 (e)
62.89 %
9.94 %
6.48 %
Jan 1, 2023 (e)
62.89 %
19.94 %
14.40 %
Jan 1, 2024 (e)
62.89 %
27.08 %
19.41 %
Jan 1, 2025 (e)
62.89 %
46.25 %
34.90 %
Jan 1, 2026 (e)
62.89 %
79.01 %
62.76 %

Antares Pharma Stock analysis

What does Antares Pharma do? The company Antares Pharma Inc was founded in 1979 in Minneapolis, USA. It has since become a successful company in the field of drug development and marketing. The company has been listed on the NASDAQ since 2006. Antares Pharma is a pharmaceutical company specializing in the development of injectable medications. Their business model is to develop innovative injectable products that meet the needs of patients and doctors, and are able to improve their therapy experience and increase adherence. The company specializes in three areas: self-injection systems, automatic devices, and pharmaceutical products. The innovation power behind Antares Pharma's development work is an important factor in their success, as well as their skills in market research and marketing. One of the company's main products is the VIBEX Pen, an automatic injection device that can be operated by patients themselves and filled with various therapeutics. The device provides an easy and painless way to administer medications. The company also produces the Makena auto-injector, which is used in pregnancy treatment. Another important product is the QuickShot auto-injector, a proprietary device used by patients to administer hormone preparations, immunomodulators, and various other common therapeutics. Due to its many years of experience and good reputation in the market, Antares Pharma has strong collaborative relationships with the pharmaceutical industry. The company's customers include reputable pharmaceutical companies such as Pfizer, Teva, Merck, and Novartis, who utilize the company's expertise to bring their own products to the market. Antares Pharma is headquartered in Ewing Township, New Jersey, USA. The company employs a variety of research and development experts who are constantly working to develop new medications and therapy approaches. It has strengthened its position as a major player in the pharmaceutical market and its goal remains to continue creating innovative solutions in the industry. Answer: Antares Pharma Inc. is a successful pharmaceutical company specializing in the development and marketing of injectable medications. They are known for their innovative products that improve therapy experiences and increase adherence. With a strong presence in the pharmaceutical market, Antares Pharma collaborates with renowned companies and continues to strive for innovative solutions. Antares Pharma is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Antares Pharma's EBIT

Antares Pharma's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Antares Pharma's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Antares Pharma's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Antares Pharma’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Antares Pharma stock

EBIT of Antares Pharma is 65.93 M USD in 2021.

EBIT of Antares Pharma changed from 13.71 M USD to 65.93 M USD, representing a 380.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Antares Pharma since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Antares Pharma historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Antares Pharma

All Key Metrics — Antares Pharma